Showing results (341-350 of 1,502) with videos related to

Sort By:
Pageof 151
Familial Cancer|May 28, 2011
Peutz-Jeghers syndrome: a patient's viewStephanie Sugars
Familial Cancer|February 28, 2012
Families' experience of oncogenetic counselling: accounts from a heterogeneous hereditary cancer risk populationÁlvaro Mendes, Liliana Sousa
Familial Cancer|November 11, 2016
Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiencyLior H Katz, Shailesh Advani, Allison M Burton-Chase, et al.
Familial Cancer|July 6, 2026
Endoscopic detection of signet ring cell carcinoma in CDH1 carriers: a 15-year single-centre experienceOmar Salehi, Douglas Tjandra, Jadon Karp, et al.
Familial Cancer|June 19, 2026
Monoallelic NTHL1 p.(Gln90*) and cancer risk: evidence from a large Turkish cohortEsma Ertürkmen Aru, Afife Büke, Hanife Saat, et al.
Familial Cancer|July 22, 2026
Impact of updated NCCN guidelines on clinical management and risk communication for CHEK2 p.I157T carriers in breast cancerEmma A Kell, Michael P Mullane, Jennifer L Geurts, et al.
Familial Cancer|September 2, 2026
Lynch syndrome-associated urothelial carcinoma: clinical and molecular findings from a single-institution cohortA Rametta, M Barella, A Scardino, et al.
Familial Cancer|October 24, 2020
Identification and management of Lynch syndrome in the Middle East and North African countries: outcome of a survey in 12 countriesMohammad Sina, Zeinab Ghorbanoghli, Amal Abedrabbo, et al.
Familial Cancer|January 31, 2020
Detection of DNA mismatch repair deficient crypts in random colonoscopic biopsies identifies Lynch syndrome patientsRandall E Brand, Beth Dudley, Eve Karloski, et al.
Familial Cancer|February 1, 2020
Prevalence of CNV-neutral structural genomic rearrangements in MLH1, MSH2, and PMS2 not detectable in routine NGS diagnosticsMonika Morak, Verena Steinke-Lange, Trisari Massdorf, et al.
Pageof 151